Physician profile
Matthew E Sterling
NPI 1891056792
$12,081.72
in general payments reported to CMS, 2019-2025
51 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,841 · 2020: $582 · 2021: $820 · 2022: $782 · 2023: $2,245 · 2024: $2,298 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,918 · Travel and Lodging: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,918.42 |
| Travel and Lodging | $139.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,039.16 | 2019-2025 | Lithovue, Rezum Generator, Spaceoar Vue System - 10ml |
| Dendreon Pharmaceuticals LLC | $1,424.51 | 2019-2025 | Provenge |
| Medtronic, INC. | $934.48 | 2021-2024 | Interstim |
| Procept Biorobotics Corporation | $740.93 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $640.30 | 2019-2025 | |
| Astellas Pharma US INC | $540.41 | 2019-2024 | Xtandi, Myrbetriq, Veozah |
| Janssen Biotech, INC. | $510.85 | 2019-2025 | Erleada |
| Coloplast Corp | $496.27 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $459.62 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $445.86 | 2020-2025 | |
| Tolmar, INC. | $396.88 | 2023-2025 | Jatenzo, Eligard |
| Pfizer INC. | $394.18 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $376.55 | 2019-2024 | Adstiladrin |
| Medtronic USA, INC. | $251.41 | 2019-2020 | |
| Cook Medical LLC | $216.12 | 2021-2024 | Litho 150, Cook |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sterling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.